ALKS vs LMT · P/E 14, rev $1.56B vs P/E 20, rev $75.05B
Alkermes Plc (ALKS) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the ALKS and LMT stock pages for the full models.
Not investment advice.